Logo do repositório

In-vitro polymicrobial oral biofilm model represents clinical microbial profile and disease progression during implant-related infections

dc.contributor.authorDini, Caroline
dc.contributor.authorCosta, Raphael Cavalcante
dc.contributor.authorBertolini, Martinna
dc.contributor.authorShibli, Jamil Awad
dc.contributor.authorFeres, Magda
dc.contributor.authorKlein, Marlise Inêz
dc.contributor.authorde Avila, Érica Dorigatti [UNESP]
dc.contributor.authorSouza, João Gabriel Silva
dc.contributor.authorBarão, Valentim Adelino Ricardo
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionUniversity of Pittsburgh
dc.contributor.institutionGuarulhos University
dc.contributor.institutionHarvard School of Dental Medicine
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2025-04-29T18:56:37Z
dc.date.issued2023-11-01
dc.description.abstractAim: Clinically relevant in-vitro biofilm models are essential and valuable tools for mechanistically dissecting the etiopathogenesis of infectious diseases and test new antimicrobial therapies. Thus, the aim of this study was to develop and test a clinically relevant in-vitro oral polymicrobial biofilm model that mimics implant-related infections in terms of microbial profile. Methods and Results: For this purpose, 24-well plate system was used to model oral biofilms, using three different microbial inoculums to grow in-vitro biofilms: (1) human saliva from periodontally healthy patients; (2) saliva as in inoculum 1 + Porphyromonas gingivalis strain; and (3) supra and subgingival biofilm collected from peri-implant sites of patients diagnosed with peri-implantitis. Biofilms were grown to represent the dynamic transition from an aerobic to anaerobic community profile. Subsequently, biofilms were collected after each phase and evaluated for microbiological composition, microbial counts, biofilm biomass, structure, and susceptibility to chlorhexidine (CHX). Results showed higher live cell count (P < .05) for biofilms developed from patients’ biofilm inoculum, but biomass volume, dry weight, and microbiological composition were similar among groups (P > .05). Interestingly, according to the checkerboard DNA–DNA hybridization results, the biofilm developed from stimulated human saliva exhibited a microbial composition more similar to the clinical subgingival biofilm of patients with peri-implantitis, with proportions of the main pathogens closer to those found in the disease. In addition, biofilm developed using saliva as inoculum was shown to be susceptible to CHX with significant reduction in bacteria compared with biofilms without exposure to CHX (P < .05). Conclusion: The findings suggested that the in-vitro polymicrobial biofilm developed from human saliva as inoculum is a suitable model and clinically relevant tool for mimicking the microbial composition of implant-related infections.en
dc.description.affiliationDepartment of Prosthodontics and Periodontology Piracicaba Dental School Universidade Estadual de Campinas (UNICAMP), SP
dc.description.affiliationDepartment of Periodontics and Preventive Dentistry School of Dental Medicine University of Pittsburgh
dc.description.affiliationDental Research Division Guarulhos University, SP
dc.description.affiliationDepartment of Oral Medicine Infection and Immunity Harvard School of Dental Medicine
dc.description.affiliationDepartment of Oral Diagnosis Piracicaba Dental School Universidade Estadual de Campinas (UNICAMP), SP
dc.description.affiliationDepartment of Dental Materials and Prosthodontics School of Dentistry at Araraquara São Paulo State University (UNESP), SP
dc.description.affiliationDepartment of Dental Materials and Prosthodontics School of Dentistry at Araçatuba São Paulo State University (UNESP), SP
dc.description.affiliationUnespDepartment of Dental Materials and Prosthodontics School of Dentistry at Araraquara São Paulo State University (UNESP), SP
dc.description.affiliationUnespDepartment of Dental Materials and Prosthodontics School of Dentistry at Araçatuba São Paulo State University (UNESP), SP
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipIdCNPq: #307471/2021-7
dc.description.sponsorshipIdCNPq: #311368/2019-0
dc.description.sponsorshipIdCAPES: 001
dc.description.sponsorshipIdFAPESP: 2018/20719-3
dc.description.sponsorshipIdFAPESP: 2020/05231-4
dc.description.sponsorshipIdFAPESP: 2020/05234-3
dc.description.sponsorshipIdFAPESP: 2021/09434-0
dc.identifierhttp://dx.doi.org/10.1093/jambio/lxad265
dc.identifier.citationJournal of Applied Microbiology, v. 134, n. 11, 2023.
dc.identifier.doi10.1093/jambio/lxad265
dc.identifier.issn1365-2672
dc.identifier.issn1364-5072
dc.identifier.scopus2-s2.0-85192219208
dc.identifier.urihttps://hdl.handle.net/11449/300882
dc.language.isoeng
dc.relation.ispartofJournal of Applied Microbiology
dc.sourceScopus
dc.subjectbiofilm
dc.subjectdental implants
dc.subjectin-vitro models
dc.subjectperi-implantitis
dc.titleIn-vitro polymicrobial oral biofilm model represents clinical microbial profile and disease progression during implant-related infectionsen
dc.typeArtigopt
dspace.entity.typePublication
relation.isOrgUnitOfPublication8b3335a4-1163-438a-a0e2-921a46e0380d
relation.isOrgUnitOfPublicationca4c0298-cd82-48ee-a9c8-c97704bac2b0
relation.isOrgUnitOfPublication.latestForDiscovery8b3335a4-1163-438a-a0e2-921a46e0380d
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Odontologia, Araraquarapt
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Odontologia, Araçatubapt

Arquivos